{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:45:49Z","timestamp":1771515949314,"version":"3.50.1"},"reference-count":73,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2018,12,11]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Sudden Cardiac Death (SCD) is a significant health problem worldwide.<\/jats:p>\n<jats:p>Multiple randomized controlled trials have shown that Implantable Cardioverter Defibrillators\n(ICDs) are effective life-saving management option for individuals at risk of SCD in both primary\nand secondary prevention. Although the conventional transvenous ICDs (TV-ICDs) are safe and\neffective, there are potential complications associated with its use, including localized pocket or\nwound infection or systematic infection, a vascular access related complication such as pneumothorax,\nand venous thrombosis, and lead related complications such as dislodgement, malfunction, and\nperforation.\n<\/jats:p>\n<jats:p>\nFurthermore, transvenous leads placement may not be feasible in certain patients like those with\nvenous anomaly or occlusion, or with the presence of intracardiac shunts. Transvenous leads extraction,\nwhen needed, is associated with considerable morbidity &amp; mortality and requires significant\nskills and costs. Totally subcutaneous ICD (S-ICD) is designed to afford the same life-saving\nbenefit of the conventional TV-ICDs while avoiding the shortcomings of the TV-leads and to simplify\nthe implant techniques and hence expand the use of ICDs in clinical practice. It becomes\ncommercially available after receiving CE mark in 2009, and its use increased significantly after its\nFDA approval in 2012. This review aims to give an overview of the S-ICD system components,\nimplantation procedure, clinical indications, safety, efficacy, and future directions.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x14666180716164740","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:03:28Z","timestamp":1531829008000},"page":"38-48","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Subcutaneous Implantable Cardioverter Defibrillators: An Overview of Implantation Techniques and Clinical Outcomes"],"prefix":"10.2174","volume":"15","author":[{"given":"Bandar","family":"Al-Ghamdi","sequence":"first","affiliation":[{"name":"Alfaisal University, College of Medicine, King Faisal Specialist Hospital & Research Centre, Zahrawi St, Al Maather, Riyadh 12713, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","volume":"98","author":"Zipes D.P.","year":"1998","unstructured":"Zipes DP, Wellens HJ. Circulation, Sudden cardiac death.,, 1998, 98,, 2334-2351,","journal-title":"Circulation"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000554","volume":"137","author":"","year":"2018","unstructured":". Circulation, Benjamin EJ, Virani SS, Callaway CW, et al on behalf of On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142018 update. A Report From the American Heart Association.,Writing Group Members, 2018, 137,, e1-e441,","journal-title":"Circulation"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"Buxton A.E.","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD. N Engl J Med, For the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease.,, 1999, 341,, 1882-1890,","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"Moss A.J.","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS. N Engl J Med,  For the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.,, 1996, 335,, 1933-1940,","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"Moss A.J.","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ. N Engl J Med, For the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.,, 2002, 346,, 877-883,","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"Bardy G.H.","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB. N Engl J Med,  For the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter\u2013 defibrillator for congestive heart failure.,, 2005, 352,, 225-237,","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","volume":"337","author":"","year":"1997","unstructured":". N Engl J Med, Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias.,, 1997, 337,, 1576-1584,","journal-title":"N Engl J Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","volume":"21","author":"Connolly S.J.","year":"2000","unstructured":"Connolly SJ, Hallstrom AP, Cappato R. Eur Heart J, Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study.,, 2000, 21,, 2071-2078,","journal-title":"Eur Heart J"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM198008073030607","volume":"303","author":"Mirowski M.","year":"1980","unstructured":"Mirowski M, Reid PR, Mower MM. N Engl J Med, Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.,, 1980, 303,, 322-324,","journal-title":"N Engl J Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","volume":"363","author":"Bardy G.H.","year":"2010","unstructured":"Bardy GH, Smith WM, Hood MA. N Engl J Med, An entirely subcutaneous implantable cardioverter-defibrillator.,, 2010, 363,, 36-44,","journal-title":"N Engl J Med"},{"key":"ref=11","author":"","unstructured":", . USER\u2019S MANUAL EMBLEM\u2122 S-ICD, EMBLEM\u2122MRIS-ICD.\nAvailable at https:\/\/www.bostonscientific.com\/content\/dam\/boston scientific\/Rhythm%20Management\/portfolio-group\/EMBLEM_S-ICD\/Download_Center\/359481-001%20EMBLEM%20S-ICD%20PTM_English.pdf, , (Accessed March 5, 2018).,"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","volume":"14","author":"Gold M.R.","year":"2017","unstructured":"Gold MR, Aasbo JD, El-Chami MF. Heart Rhythm, Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.,, 2017, 14,, 1456-1463,","journal-title":"Heart Rhythm"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/pace.13314","volume":"41","author":"Chang S.C.","year":"2018","unstructured":"Chang SC, Patton KK, Robinson MR, Poole JE, Prutkin JM. Pacing Clin Electrophysiol, Subcutaneous ICD screening with the Boston Scientific ZOOM programmer versus a 12-lead ECG machine.,, 2018, 41,, 511-516,","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/eut370","volume":"16","author":"Randles D.A.","year":"2013","unstructured":"Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. Europace, How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?,, 2013, 16,, 1015-1021,","journal-title":"Europace"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/jce.12343","volume":"25","author":"Olde Nordkamp L.R.","year":"2014","unstructured":"Olde Nordkamp LR, Warnaars JLF, Kooiman KM. J Cardiovasc Electrophysiol, Which patients are not suitable for a subcutaneous ICD: Incidence and predictors of failed QRS-T-wave morphology screening.,, 2014, 25,, 494-499,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","volume":"11","author":"Groh C.A.","year":"2014","unstructured":"Groh CA, Sharma S, Pelchovitz DJ. Heart Rhythm, Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.,, 2014, 11,, 1361-1366,","journal-title":"Heart Rhythm"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"Elliott P.M.","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA. Eur Heart J, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC).,, 2014, 35,, 2733-2779,","journal-title":"Eur Heart J"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"e004801","DOI":"10.1161\/CIRCEP.117.004801","volume":"10","author":"Srinivasan N.T.","year":"2017","unstructured":"Srinivasan NT, Patel KH, Qamar K. Circ Arrhythm Electrophysiol, Disease severity and exercise testing reduce subcutaneous implantable cardioverter-defibrillator left sternal ECG screening success in hypertrophic cardiomyopathy.,, 2017, 10,, e004801-,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/europace\/eux009","volume":"20","author":"Conte G.","year":"2018","unstructured":"Conte G, Kawabata M, de Asmundis C. Europace, High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: A comparison with other inherited primary arrhythmia syndromes.,, 2018, 20,, 1188-1193,","journal-title":"Europace"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00380-017-0994-3","volume":"32","author":"Kamakura T.","year":"2017","unstructured":"Kamakura T, Wada M, Ishibashi K. Heart Vessels, Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.,, 2017, 32,, 1277-1283,","journal-title":"Heart Vessels"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/eurheartj\/sum070","volume":"9","author":"Sarkozy A.","year":"2007","unstructured":"Sarkozy A, Brugada P, Mont L, Brugada J. Eur Heart J, Optimizing the clinical use of implantable defibrillators in patients with Brugada syndrome.,, 2007, 9,, 174-180,","journal-title":"Eur Heart J"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.amjcard.2013.03.048","volume":"112","author":"Zorzi A.","year":"2013","unstructured":"Zorzi A, ElMaghawry M, Rigato I. Am J Cardiol, Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy.,, 2013, 112,, 411-415,","journal-title":"Am J Cardiol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jacep.2016.10.014","volume":"3","author":"Migliore F.","year":"2017","unstructured":"Migliore F, Bertaglia E, Zorzi A, Corrado D. JACC Clin Electrophysiol, Cardioverter-defibrillator and arrhythmogenic right ventricular cardiomyopathy the importance of repeat ECG screening during exercise test.,, 2017, 3,, 785-786,","journal-title":"JACC Clin Electrophysiol"},{"key":"ref=24","first-page":"1059","volume":"17","author":"Zeb M.","year":"2015","unstructured":"Zeb M, Curzen N, Veldtman G. Europace, Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter defibrillator based on surface electrocardiogram mapping.,, 2015, 17,, 1059-1067,","journal-title":"Europace"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jacep.2016.02.011","volume":"2","author":"Brouwer T.F.","year":"2016","unstructured":"Brouwer TF, Kooiman KM, Olde Nordkamp LR, van Halm VP, Knops RE. JACC Clin Electrophysiol, Algorithm-based screening may improve patient selection for the subcutaneous implantable defibrillator.,, 2016, 2,, 605-614,","journal-title":"JACC Clin Electrophysiol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1053\/j.jvca.2016.06.007","volume":"30","author":"Essandoh M.K.","year":"2016","unstructured":"Essandoh MK, Otey AJ, Abdel-Rasoul M. J Cardiothorac Vasc Anesth, Monitored anesthesia care for subcutaneous cardioverter-defibrillator implantation: A single-center experience.,, 2016, 30,, 1228-1233,","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"e004663","DOI":"10.1161\/CIRCEP.116.004663","volume":"10","author":"Brouwer T.F.","year":"2017","unstructured":"Brouwer TF, Miller MA, Quast AB. Circ Arrhythm Electrophysiol, Implantation of the subcutaneous implantable cardioverter-defibrillator: An evaluation of 4 implantation techniques.,, 2017, 10,, e004663-,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.joa.2016.01.005","volume":"32","author":"Ferrari P.","year":"2016","unstructured":"Ferrari P, Giofr\u00e8 F, De Filippo P. J Arrhythm, Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience.,, 2016, 32,, 223-226,","journal-title":"J Arrhythm"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","volume":"10","author":"Knops R.E.","year":"2013","unstructured":"Knops RE, Olde Nordkamp LR, de Groot JR, Wilde AA. Heart Rhythm, Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.,, 2013, 10,, 1240-1243,","journal-title":"Heart Rhythm"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/pace.12987","volume":"40","author":"Migliore F.","year":"2017","unstructured":"Migliore F, Allocca G, Calzolari V. Pacing Clin Electrophysiol, Intermuscular two-incision technique for subcutaneous implantable cardioverter defibrillator implantation: Results from a multicenter registry.,, 2017, 40,, 278-285,","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1540-8159.1987.tb05926.x","volume":"10","author":"Rattes M.F.","year":"1987","unstructured":"Rattes MF, Jones DL, Sharma AD, Klein GJ. Pacing Clin Electrophysiol, Defibrillation threshold: A simple and quantitative estimate of the ability to defibrillate.,, 1987, 10,, 70-77,","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(14)61903-6","volume":"385","author":"Healey J.S.","year":"2015","unstructured":"Healey JS, Hohnloser SH, Glikson M. Lancet, Shockless IMPLant Evaluation [SIMPLE] Investigators. Cardioverter defibrillator implantation without induction of ventricular fibrillation: A single-blind, non-inferiority, randomised controlled trial (SIMPLE).,, 2015, 385,, 785-791,","journal-title":"Lancet"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.14740\/cr638w","volume":"8","author":"Al-Ghamdi B.","year":"2017","unstructured":"Al-Ghamdi B, Shafquat A, Alruwaili N, Emmanual S, Shoukri M, Mallawi Y. Cardiol Res, Subcutaneous implantable cardioverter defibrillators implantation without defibrillation threshold testing: A single center experience.,, 2017, 8,, 319-326,","journal-title":"Cardiol Res"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","volume":"35","author":"Lambiase P.D.","year":"2014","unstructured":"Lambiase PD, Barr C, Theuns DA. Eur Heart J, EFFORTLESS Investigators Worldwide experience with a totally subcutaneous implantable defibrillator: Early results from the EFFORTLESS S-ICD Registry.,, 2014, 35,, 1657-1665,","journal-title":"Eur Heart J"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","volume":"23","author":"Gold M.R.","year":"2012","unstructured":"Gold MR, Theuns DA, Knight BP. J Cardiovasc Electrophysiol, Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: The START study.,, 2012, 23,, 359-366,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","volume":"65","author":"Burke M.C.","year":"2015","unstructured":"Burke MC, Gold MR, Knight BP. J Am Coll Cardiol, Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry.,, 2015, 65,, 1605-1615,","journal-title":"J Am Coll Cardiol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/eurheartj\/ehs017","volume":"33","author":"Jarman J.W.","year":"2012","unstructured":"Jarman JW, Lascelles K, Wong T. Eur Heart J, Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: Cause for caution.,, 2012, 33,, 1351-1359,","journal-title":"Eur Heart J"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"Weiss R.","year":"2013","unstructured":"Weiss R, Knight BP, Gold MR. Circulation, Safety and efficacy of a totally subcutaneous implantablecardioverter defibrillator.,, 2013, 128,, 944-953,","journal-title":"Circulation"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","volume":"60","author":"Olde Nordkamp L.R.","year":"2012","unstructured":"Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV. J Am Coll Cardiol, The entirely subcutaneous implantable cardioverter-defibrillator: Initial clinical experience in a large Dutch cohort.,, 2012, 60,, 1933-1939,","journal-title":"J Am Coll Cardiol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.hrthm.2007.08.007","volume":"4","author":"Wilkoff B.L.","year":"2007","unstructured":"Wilkoff BL. Heart Rhythm, How to treat and identify device infections.,, 2007, 4,, 1467-1470,","journal-title":"Heart Rhythm"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1540-8159.2010.02991.x","volume":"34","author":"Le K.Y.","year":"2011","unstructured":"Le KY, Sohail MR, Friedman PA. PACE, for the Mayo Cardiovascular Infections Study Group Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis.,, 2011, 34,, 450-459,","journal-title":"PACE"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","volume":"10","author":"K\u00f6be J.","year":"2013","unstructured":"K\u00f6be J, Reinke F, Meyer C. Heart Rhythm, Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: A multicenter case-control study.,, 2013, 10,, 29-36,","journal-title":"Heart Rhythm"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"e000198","DOI":"10.1136\/openhrt-2014-000198","volume":"2","author":"Ezzat V.A.","year":"2015","unstructured":"Ezzat VA, Lee V, Ahsan S. Open Heart, A systematic review of ICD complications in randomised controlled trials versus registries: Is our \u2018real-world\u2019 data an underestimation?,, 2015, 2,, e000198-,","journal-title":"Open Heart"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.111.046995","volume":"125","author":"Freeman J.V.","year":"2012","unstructured":"Freeman JV, Wang Y, Curtis JP. Circulation, Physician procedure volume and complications of cardioverter-defibrillator implantation.,, 2012, 125,, 57-64,","journal-title":"Circulation"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2011.06.007","volume":"58","author":"van Rees J.B.","year":"2011","unstructured":"van Rees JB, de Bie MK, Thijssen J. J Am Coll Cardiol, Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: A systematic review of randomized clinical trials.,, 2011, 58,, 995-1000,","journal-title":"J Am Coll Cardiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/europace\/eut016","volume":"15","author":"Jarman J.W.","year":"2013","unstructured":"Jarman JW, Todd DM. Europace, United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: Important lessons to learn.,, 2013, 15,, 1158-1165,","journal-title":"Europace"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jacc.2015.11.026","volume":"67","author":"Lewis G.F.","year":"2016","unstructured":"Lewis GF, Gold MR. J Am Coll Cardiol, Safety and efficacy of the subcutaneous implantable defibrillator.,, 2016, 67,, 445-454,","journal-title":"J Am Coll Cardiol"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCEP.115.002953","volume":"8","author":"Theuns D.A.","year":"2015","unstructured":"Theuns DA, Crozier IG, Barr CS. Circ Arrhythm Electrophysiol, Longevity of the subcutaneous implantable defibrillator: Long-term follow-up of the European Regulatory Trial Cohort.,, 2015, 8,, 1159-1163,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","volume":"115","author":"Kleemann T.","year":"2007","unstructured":"Kleemann T, Becker T, Doenges K. Circulation, Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.,, 2007, 115,, 2474-2480,","journal-title":"Circulation"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","volume":"367","author":"Moss A.J.","year":"2012","unstructured":"Moss AJ, Schuger C, Beck CA. N Engl J Med, Reduction in inappropriate therapy and mortality through ICD programming.,MADIT-RIT Trial Investigators, 2012, 367,, 2275-2283,","journal-title":"N Engl J Med"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jce.12612","volume":"26","author":"Brisben A.J.","year":"2015","unstructured":"Brisben AJ, Burke MC, Knight BP. J Cardiovasc Electrophysiol, A new algorithm to reduce inappropriate therapy in the S-ICD system.,, 2015, 26,, 417-423,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","volume":"18","author":"Knops R.E.","year":"2016","unstructured":"Knops RE, Brouwer TF, Barr CS. Europace, The learning curve associated with the introduction of the subcutaneous implantable defibrillator.,, 2016, 18,, 1010-1015,","journal-title":"Europace"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCEP.111.964676","volume":"5","author":"Rowley C.P.","year":"2012","unstructured":"Rowley CP, Gold MR. Circ Arrhythm Electrophysiol, Subcutaneous implantable cardioverter defibrillator.,, 2012, 5,, 587-593,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.hrthm.2011.10.004","volume":"9","author":"Gold M.R.","year":"2012","unstructured":"Gold MR, Ahmad S, Browne K. Heart Rhythm, Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial.,, 2012, 9,, 370-377,","journal-title":"Heart Rhythm"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1540-8167.2011.02086.x","volume":"22","author":"Gilliam F.R.","year":"2011","unstructured":"Gilliam FR, Hayes DL, Boehmer JP. J Cardiovasc Electrophysiol, Realworld evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: The ALTITUDE REDUCES study.,, 2011, 22,, 1023-1029,","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2008.05.011","volume":"52","author":"Wilkoff B.L.","year":"2008","unstructured":"Wilkoff BL, Williamson BD, Stern RS. J Am Coll Cardiol, Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.,PREPARE Study Investigators, 2008, 52,, 541-550,","journal-title":"J Am Coll Cardiol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","volume":"309","author":"Gasparini M.","year":"2013","unstructured":"Gasparini M, Proclemer A, Klersy C. JAMA, Effect of long-detection interval vs. standard detection interval for implantable cardioverter defibrillators on antitachycardia pacing and shock delivery: The ADVANCE III randomized clinical trial.,, 2013, 309,, 1903-1911,","journal-title":"JAMA"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCEP.114.001614","volume":"7","author":"Zipse M.M.","year":"2014","unstructured":"Zipse MM, Sauer WH, Varosy PD, Aleong RG, Nguyen DT. Circ Arrhythm Electrophysiol, Inappropriate shocks due to subcutaneous air in a patient with a subcutaneous cardiac defibrillator.,, 2014, 7,, 768-770,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/j.crvasa.2017.05.016","volume":"60","author":"Crea P.","year":"2018","unstructured":"Crea P, Nicotera A, Crea B, Taormina A, Picciolo G. Cor et Vasa, An anomalous case of S-ICD malfunctioning: A big trouble or a soap bubble?,, 2018, 60,, e472-e474,","journal-title":"Cor et Vasa"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCEP.113.001139","volume":"7","author":"Winter J.","year":"2014","unstructured":"Winter J, Kohlmeier A, Shin DI, O\u2019Connor S. Circ Arrhythm Electrophysiol, Subcutaneous implantable cardioverter-defibrillators and sternal wires: A cautionary tale.,, 2014, 7,, 986-987,","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori S.G.","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A. Eur Heart J, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).,ESC Scientific Document Group, 2015, 36,, 2793-2867,","journal-title":"Eur Heart J"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cjca.2016.09.009","volume":"33","author":"Bennett M.","year":"2017","unstructured":"Bennett M, Parkash R, Nery P. Can J Cardiol, Canadian cardiovascular society\/Canadian heart rhythm society 2016 implantable cardioverter-defibrillator guidelines.,, 2017, 33,, 174-188,","journal-title":"Can J Cardiol"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"Al-Khatib S.M.","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ. J Am Coll Cardiol, AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.,, 2018, 72,, 1677-1749,","journal-title":"J Am Coll Cardiol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.joa.2013.05.001","volume":"29","author":"Varma N.","year":"2013","unstructured":"Varma N. J Arrhythm, Remote monitoring of ICDs and CRTs.,, 2013, 29,, 144-152,","journal-title":"J Arrhythm"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2014.10.036","volume":"115","author":"Porterfield C.","year":"2015","unstructured":"Porterfield C, DiMarco JP, Mason PK. Am J Cardiol, Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker.,, 2015, 115,, 276-278,","journal-title":"Am J Cardiol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.hrthm.2015.06.022","volume":"12","author":"Kuschyk J.","year":"2015","unstructured":"Kuschyk J, Stach K, T\u00fcl\u00fcmen E. Heart Rhythm, The subcutaneous implantable cardioverter-defibrillator \u2013 First single center experience with other cardiac implantable electronic devices.,, 2015, 12,, 2230-2238,","journal-title":"Heart Rhythm"},{"key":"ref=67","first-page":"74","volume":"8","author":"R\u00f6ger S.","year":"2015","unstructured":"R\u00f6ger S, Borggrefe M, Kuschyk J. J Atr Fibrillation, Heart failure with reduced ejection fraction and a narrow QRS complex: Combination of a subcutaneous defibrillator with cardiac contractility modulation.,, 2015, 8,, 74-78,","journal-title":"J Atr Fibrillation"},{"key":"ref=68","author":"Al-Ghamdi B","year":"","unstructured":"Al-Ghamdi B, Shafquat A, Mallawi Y. , Cardiac contractility modulation\ndevice and subcutaneous implantable cardioverter defibrillator\ncombination: A new hope for heart failure patients with low\nejection fraction and narrow qrs complex. J Cardiovasc Med Cardiol\n2016; 3(1): 018-22.,"},{"key":"ref=69","author":"Poole JE","year":"","unstructured":"Poole JE, Gold MR. , Who should receive the subcutaneous implanted\ndefibrillator? The subcutaneous implantable cardioverter\ndefibrillator (ICD) should be considered in all ICD patients who do\nnot require pacing. Circ Arrhythmia Electrophysiol 2013; 6: 1236-\n44. discussion 1244-5., ,"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacep.2017.04.002","volume":"3","author":"Tjong F.V.Y.","year":"2017","unstructured":"Tjong FVY, Brouwer TF, Koop B. JACC Clin Electrophysiol, Acute and 3-month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator.,, 2017, 3,, 1487-1498,","journal-title":"JACC Clin Electrophysiol"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","volume":"163","author":"Olde Nordkamp L.R.","year":"2012","unstructured":"Olde Nordkamp LR, Knops RE, Bardy GH. Am Heart J, Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.,, 2012, 163,, 753-760,","journal-title":"Am Heart J"},{"key":"ref=72","author":"","unstructured":"Available at, .  https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02881255, ,  (Accessed on: March 10, 2018). ,"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ahj.2017.04.014","volume":"189","author":"Kutyifa V.","year":"2017","unstructured":"Kutyifa V, Beck C, Brown MW. Am Heart J, MADIT S-ICD Executive Committee. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.,, 2017, 189,, 158-166,","journal-title":"Am Heart J"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T14:01:52Z","timestamp":1563458512000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163812\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x14666180716164740","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}